Vietnam to receive 4.9 million doses of AstraZeneca COVID-19 vaccine
Covax is a public health initiative co-led by the World Health Organization (WHO), the Gavi, The Vaccine Alliance, the Coalition for Epidemic Preparedness Innovations (CEPI). (Photo: VN Express) |
Mr. Dang Viet Hung, Department of International Cooperation, Ministry of Health, on the afternoon of February 5, confirmed the information that Vietnam will receive about 4.9 million doses of AstraZeneca's COVID-19 vaccine.
Accordingly, on January 29, Covax sent a letter announcing that in the first quarter of 2021, it would deliver to Vietnam about 25% of the contracted Covid-19 vaccine, equivalent to about 4.9 to 8.2 million doses. The remainder will be shipped to Vietnam in the second quarter. However, it is not clear when the vaccine will arrive in Vietnam.
Answering to VnExpress that afternoon, the representative of the British Embassy in Vietnam also said that about 2.5 million Vietnamese people will be vaccinated through the program of Covax.
Covax is a public health initiative co-led by the World Health Organization (WHO), the Gavi, The Vaccine Alliance, the Coalition for Epidemic Preparedness Innovations (CEPI), established to ensure global access to public vaccines.
On February 1, AstraZeneca signed a cooperation agreement to supply 30 million doses of the Covid-19 vaccine to the Vietnam Vaccination Center in the first half of 2021. (Photo: BBC) |
On Feb. 3, Covax said it would ship 336 million doses of the AstraZeneca-Oxford vaccine to 145 countries in the first half of this year. This is enough to reach an average vaccination rate that covers 3.3% of the total population of 145 member countries.
On February 1, AstraZeneca signed a cooperation agreement to supply 30 million doses of the Covid-19 vaccine to the Vietnam Vaccination Center in the first half of 2021. The new agreement helps to supply the number of injections to prevent COVID-19. In the future, Vietnam aims to fully immunize nearly 100 million people.
Four Vietnamese firms are researching and developing vaccines against COVID-19. Two of them are carrying out clinical trials of their vaccines, Nano Covax and Covivac. The locally-made vaccines are due to be commercially marketed later this year.
Vaccine AstraZeneca/Oxford is developed by vector technology, using harmless flu virus (adenovirus) from chimpanzees in the laboratory. The vaccine contains genes from nCoV virus. When injected into human cells, they create proteins that help the immune system recognize and respond to pathogens in the future.
Vietnam COVID-19 Updates (Feb 6): Second morning of no new cases According to the 6 am news of the National Steering Committee for COVID-19 Prevention and Control, on the morning of February 6, Vietnam did not ... |
Hai Phong strictly controls people entering and leaving city amid Covid-19 fears Hai Phong City People's Committee on February 5 issued an announcement which requests to strictly control all people entering and leaving the city starting 12 ... |
53 localities allow school leave due to COVID, online teaching activated nationwide According to the report of the Ministry of Education and Training, by the end of February 4, 53 localities allow early school leaves to prevent ... |